A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse — where CAR T cells bind to cancer cells — affect anticancer activity.
A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior
